A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates

Safe, efficacious, and deployable vaccines are urgently needed to control COVID-19 in the large-scale vaccination campaigns. We report here the preclinical studies of an approved protein subunit vaccine against COVID-19, ZF2001, which contains tandem-repeat dimeric receptor-binding domain (RBD) prot...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yaling, Li, Shihua, Jin, Xiyue, Han, Jian-bao, Xu, Kun, Xu, Senyu, Han, Yuxuan, Liu, Chuanyu, Zheng, Tianyi, Liu, Mei, Yang, Mi, Song, Tian-Zhang, Huang, Baoying, Zhao, Li, Wang, Wen, A, Ruhan, Cheng, Yingjie, Wu, Changwei, Huang, Enqi, Yang, Shilong, Wong, Gary, Bi, Yuhai, Ke, Changwen, Tan, Wenjie, Yan, Jinghua, Zheng, Yong-Tang, Dai, Lianpan, Gao, George F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009945/
https://www.ncbi.nlm.nih.gov/pubmed/35311493
http://dx.doi.org/10.1080/22221751.2022.2056524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009945/
https://www.ncbi.nlm.nih.gov/pubmed/35311493
http://dx.doi.org/10.1080/22221751.2022.2056524

Ejemplares similares